A steroid to treat eye pain, a nontraditional OCD treatment & more: 4 latest FDA approvals

Here are the four latest drugs or medical devices approved by the FDA since Aug. 17:

1. Oxervate is a topical eyedrop that contains cenegermin. The drug treats neurotropic keratitis, a rare degenerative disease resulting in the loss of sensation in the cornea, which causes damage. It is the first drug approved in the U.S. to treat the disease.

2. Brainsway, an Israeli-based medical device manufacturer, received approval to market its Brainsway Deep Transcranial Magnetic Stimulation System to treat obsessive compulsive disorder. The system is intended for use in patients with OCD that haven't responded to traditional treatments.

3. Inveltys, a twice-daily ocular corticosteroid, is used to treat postoperative inflammation and pain after eye surgery.

4. Shire, a drugmaker based in Ireland, won approval for Takhzyro, a first-of-its-kind injection to prevent attacks of a rare swelling disorder, hereditary angioedema.

More articles on supply chain:
Medical device managers rely on physicians to screen out defects, study suggests
Amazon, other shippers ask Trump administration not to raise postal rates
Hospitals don't save much on supply chain after they're acquired, report says

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.